Discontinued — last reported Q2 '23

Investing

Acquisitions

MasTec Acquisitions increased by 473.1% to $266.85M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5540.5%, from $4.73M to $266.85M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -51.1% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ4 2016
Last reportedQ2 2023

How to read this metric

High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.

Detailed definition

This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...

Peer comparison

Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.

Metric ID: acquisitions

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$500.41M$15.85M$639.70M$21.84M$23.07M$26.93M$563.92M$46.51M$17.37M$4.94M$571.00K$61.00K$0.00$33.75M$46.12M$4.73M$2.52M$17.23M$46.57M$266.85M
QoQ Change-96.8%>999%-96.6%+5.6%+16.8%>999%-91.8%-62.6%-71.6%-88.4%-89.3%-100.0%+36.7%-89.7%-46.8%+585.2%+170.2%+473.1%
YoY Change-95.4%+69.9%-11.8%+112.9%-24.7%-81.7%-99.9%-99.9%-100.0%+583.6%>999%>999%-48.9%+1.0%>999%
Range$0.00$639.70M
CAGR-12.4%
Avg YoY Growth>999%
Median YoY Growth-11.8%
Current Streak3 quarters growth

Frequently Asked Questions

What is MasTec's acquisitions?
MasTec (MTZ) reported acquisitions of $266.85M in Q1 2026.
How has MasTec's acquisitions changed year-over-year?
MasTec's acquisitions increased by 5540.5% year-over-year, from $4.73M to $266.85M.
What is the long-term trend for MasTec's acquisitions?
Over 4 years (2021 to 2025), MasTec's acquisitions has grown at a -51.1% compound annual growth rate (CAGR), from $1.24B to $71.04M.
What does acquisitions mean?
Cash spent to acquire other companies or businesses, net of cash received in the deal.